KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medpace Holdings (MEDP) EPS (Basic) (2016 - 2026)

Medpace Holdings filings provide 12 years of EPS (Basic) readings, the most recent being $4.35 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 15.38% to $4.35 in Q1 2026 year-over-year; TTM through Mar 2026 was $16.22, a 20.06% increase, with the full-year FY2025 number at $15.64, up 19.75% from a year prior.
  • EPS (Basic) hit $4.35 in Q1 2026 for Medpace Holdings, down from $4.76 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $4.76 in Q4 2025 to a low of $1.52 in Q2 2022.
  • Median EPS (Basic) over the past 5 years was $2.85 (2024), compared with a mean of $2.93.
  • Biggest five-year swings in EPS (Basic): soared 57.78% in 2022 and later grew 7.98% in 2023.
  • Medpace Holdings' EPS (Basic) stood at $2.18 in 2022, then increased by 16.97% to $2.55 in 2023, then surged by 48.24% to $3.78 in 2024, then grew by 25.93% to $4.76 in 2025, then dropped by 8.61% to $4.35 in 2026.
  • The last three reported values for EPS (Basic) were $4.35 (Q1 2026), $4.76 (Q4 2025), and $3.95 (Q3 2025) per Business Quant data.